X. Chevalier et Ja. Tyler, PRODUCTION OF BINDING-PROTEINS AND ROLE OF THE INSULIN-LIKE GROWTH-FACTOR-I BINDING-PROTEIN-3 IN HUMAN ARTICULAR-CARTILAGE EXPLANTS, British journal of rheumatology, 35(6), 1996, pp. 515-522
The aim of this study was to determine the production of insulin-like
growth factor binding proteins (IGFBP) and the role of the IGFBP-3 in
human normal (n = 2) and osteoarthritic (OA) articular cartilage (n =
14) explants. Binding proteins were studied in the medium by Western l
igand blotting and Western blotting. Proteoglycan synthesis under insu
lin-like growth factor I (IGF-I) stimulation was studied after a pulse
of (SO42-)-S-35 in the presence or absence of added IGFBP-3. Osteoart
hritic explants released a doubler of IGFBPs with a 39/43 kDa M(r) cor
responding to the binding protein 3. Constitutive production from unst
imulated OA cartilage was higher than from normal cartilage. IGF-I ind
uced a 20-fold increase and IL-1 a 2-fold increase in IGFBP-3 release.
A minor band around 30 kDa was also detectable. Studies of proteoglyc
an (PG) synthesis showed that the majority of OA cartilage explant sam
ples responded weakly to IGF-I (100 ng/ml) stimulation (+33%), while t
he others were high responders (+180%). Co-incubation of IGF-I with re
combinant (r) IGFBP-3 did not affect the rate of PG synthesis. However
, while pre-incubation with rIGFBP3 for 72 h did not change the rate o
f PG synthesis in the high-responder group, it strongly increased PG s
ynthesis in the low-responder group. this study demonstrates that the
ability of IGF-I to enhance proteoglycan synthesis varied among the OA
samples and may in part be dependent on the local level of IGFBP-3. T
his implies pathophysiological considerations in the limits of IGF-I a
ction during the OA process.